ASCO 2013 Report – Lambrolizumab immunotherapy shows efficacy in advanced melanoma
Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.
Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.
by Bruce Sylvester – over 30,000 clinicians and researchers attended the American Society of Clinical Oncology 2013 annual meeting in Chicago on May 31-June 4. Among the most… read more.
Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study.
Greater sensitivity, with lower radiation dose, allows for faster treatment, reported at 93rd AATS Annual Meeting. Lung cancer is associated with very high mortality, in part because it… read more.
FDA Highlights by Bruce Sylvester – Patients suffering chemotherapy-induced peripheral neuropathy treated with the anti-depressant duloxetine for 5 weeks achieved a greater reduction in pain compared with patients… read more.
Effects reduced by up to 30 percent by low-vitamin D season. For women diagnosed with oestrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in… read more.
Taken from The Lancet – by Bruce Sylvester – Short-term folic acid supplement use does not affect overall cancer risk and does little to increase the risk of… read more.
A special report published by the BMJ finds that thousands of melanoma patients around the world are undergoing an expensive and invasive procedure called sentinel node biopsy, despite a… read more.
Colon cancer develops slowly. Precancerous lesions usually need many years to turn into a dangerous carcinoma. They are well detectable in an endoscopic examination of the colon called… read more.
Smartphone applications that claim to evaluate a user’s photographs of skin lesions for the likelihood of cancer instead returned highly variable and often inaccurate feedback, according to a… read more.
A lifelong diet rich in omega-3 fatty acids can inhibit growth of breast cancer tumours by 30 per cent, according to new research. The study, published recently in… read more.
by Ed Susman – Orlando, Florida – Researchers said they were surprised to find that prostate cancer patients treated with anticoagulants appear to achieve a longer median overall… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.